Open AccessA review of the key issues associated with the commercialization of biobanks
Author(s) -
Timothy Caulfield,
Sarah Burningham,
Yann Joly,
Zubin Master,
Mahsa Shabani,
Pascal Borry,
Allan B. Becker,
Michael Burgess,
Kathryn Calder,
Christine Critchley,
Kelly Edwards,
Stephanie M. Fullerton,
Herbert Gottweis,
Robyn Hyde-Lay,
Judy Illes,
Rosario Isasi,
Yoshihiro Kato,
Jane Kaye,
Bartha Maria Knoppers,
John Lynch,
Amy L. McGuire,
Eric M. Meslin,
Dianne Nicol,
Kieran C. O’Doherty,
Ubaka Ogbogu,
Margaret Otlowski,
Daryl Pullman,
Nola M. Ries,
Chris Scott,
Malcolm R. Sears,
Helen M. Wallace,
Ma’n H. Zawati
Publication year - 2014
Publication title -
journal of law and the biosciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 18
ISSN - 2053-9711
DOI - 10.1093/jlb/lst004
Subject(s) - biobank , commercialization , key (lock) , medicine , business , computer security , computer science , biology , bioinformatics , marketing
This 'issues paper' was generated through a 'virtual workshop process' over the course of severalmonths.The authors first outlined relevant issues and key literature. A draft was then distributed, comments were received, and a revised draft was circulated among authors for approval.The use of a 'virtual workshop process' shaped both the tone and coverage of this article, though we hope in a way that still provides a detailed and useful summary of central issues on this topic.We believe that this paper-the collaborative work of globally situated ELSI researchers-exemplifies 'ELSI 2.0' (Jane Kaye et al., Research Priorities. ELSI 2.0 for Genomics and Society, 336 Science 673 (2012))
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom